Home > Result Summaries: Compounds > GSK1004723 and GSK835726 > Result Summary for 112864

Result Summary for 112864

Result Summary

Protocol ID:	112864
Clinical Study ID:	HHI112864
Official Title:	A randomised, double-blind, placebo-controlled 4-period cross-over study to assess the efficacy and safety of repeat dose intranasal GSK1004723 (1000µg), oral GSK835726 (10mg) and cetirizine (10mg) in the environmental challenge chamber in subjects with seasonal allergic rhinitis
Phase:	phase 2
Study Indications or Diseases:	Rhinitis, Allergic, Seasonal
Generic Name:	GSK1004723 and GSK835726
Trade/Product Name:	GSK1004723 and GSK835726
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Daley-Yates P, Ambery C, Sweeney L, Watson J, Oliver A, McQuade B. The efficacy and tolerability of two novel H1/H3 receptor antagonists in seasonal allergic rhinitis. [Int Arch Allergy Immunol]. 2012;158:84-98.